ArticleBone marrow transplantation2026

Long-term follow-up of belumosudil as second or subsequent line of therapy for steroid-dependent/resistant cGVHD: clinical outcomes from a Japanese study.

Koji Kato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.